Phase 1 Study of Chemoradiotherapy Combined with Nivolumab ± Ipilimumab for the Curative Treatment of Muscle-invasive Bladder Cancer

Autor: de Ruiter, Ben-Max, van Hattum, Jons W., Lipman, Djoeri, de Reijke, Theo M., van Moorselaar, R. Jeroen A., van Gennep, Erik J., Maartje Piet, A.H., Donker, Mila, van der Hulle, Tom, Voortman, Jens, Oddens, Jorg R., Hulshof, Maarten C.C.M., Bins, Adriaan D.

Publikováno v: In European Urology November 2022 82(5):518-526

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

Autor: Hagen, P. van, Hulshof, M.C.C., Lanschot, J.J. van, Steyerberg, E.W., Berge Henegouwen, M.I. van, Wijnhoven, B.P., Richel, D.J., Nieuwenhuijzen, G.A., Hospers, G.A., Bonenkamp, J.J., Cuesta, M.A., Blaisse, R.J., Busch, O.R., Kate, F.J. ten, Creemers, G.J., Punt, C.J.A., Plukker, J.T., Verheul, H.M., Spillenaar Bilgen, E.J., Dekken, H. van, Sangen, M.J. van der, Rozema, T., Biermann, K., Beukema, J.C., Piet, A.H., Rij, C.M. van, Reinders, J.G., Tilanus, H.W., Gaast, A. van der, Krieken, J.H. van

Publikováno v: New England journal of medicine, 366(22), 2074-2084. Massachussetts Medical Society
The New England Journal of Medicine, 366, 2074-84
van Hagen, P, Hulshof, M C C M, van Lanschot, J J B, Steyerberg, E W, Henegouwen, M I V, Wijnhoven, B P L, Richel, D J, Nieuwenhuijzen, G A P, Hospers, G A P, Bonenkamp, J J, Cuesta, M A, Blaisse, R J B, Busch, O R C, Ten Kate, F J W, Creemers, G J, Punt, C J A, Plukker, J T M, Verheul, H M W, Bilgen, E J S, van Dekken, H, van der Sangen, M J C, Rozema, T, Biermann, K, Beukema, J C, Piet, A H M, van Rij, C, Reinders, J G, Tilanus, H W & van der Gaast, A 2012, ' Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer ', New England Journal of Medicine, vol. 366, no. 22, pp. 2074-2084 . https://doi.org/10.1056/NEJMoa1112088
The New England Journal of Medicine, 366, 22, pp. 2074-84
New England Journal of Medicine, 366(22), 2074-2084. Massachussetts Medical Society
New England Journal of Medicine, 366(22), 2074-2084. MASSACHUSETTS MEDICAL SOC

Contains fulltext : 109134.pdf (Publisher’s version ) (Closed access) BACKGROUND: The role of neoadjuvant chemoradiotherapy in the treatment of patients with esophageal or esophagogastric-junction cancer is not well established. We compared chemora

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25d4fcd8960f10deb52c724d290f0008
https://doi.org/10.1056/nejmoa1112088